Domain > ra-option.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2016-02-10	54.231.184.99 (ClassC)
2019-06-09	52.218.218.186 (ClassC)
2024-09-06	52.218.218.162 (ClassC)
2024-10-02	52.92.243.179 (ClassC)
2025-07-20	52.218.232.234 (ClassC)
2025-09-13	3.5.80.78 (ClassC)
2025-09-18	52.92.236.43 (ClassC)
2025-09-25	52.92.235.155 (ClassC)
2026-01-24	52.92.224.171 (ClassC)

HTTP/1.1 200 OKx-amz-id-2: ARCFhyNHtssO5G3XftfF8KC9qUGLdebajubMHXvykIBkAa3B1RIQk/ysIdKMH6o2NBZBnGREzQYx-amz-request-id: M292BBDVMD0DJPBBDate: Fri, 06 Sep 2024 23:51:07 GMTLast-Modified: Fri, 28 Aug 20

!DOCTYPE html PUBLIC -//W3C//DTD XHTML 1.0 Transitional//EN http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd>!--if lt IE 7 > html classie6> !endif-->!--if IE 7 >    html classie7> !endif-->!--if IE 8 >    html classie8> !endif-->!--if IE 9 >    html classie9> !endif-->!--if (gt IE 9)|!(IE)>!--> html class> !--!endif-->head>	title>An RA Treatment Option/title>	meta charsetUTF-8>	meta http-equivX-UA-Compatible contentIEedge,chrome1 />	meta namedescription contentLearn about additional RA treatment options available to you. Find Out Here.>	!-- link relshortcut icon typeimage/x-icon hrefhttp://cdn.rasuvo.com/assets/images/favicon.ico> -->	link relstylesheet typetext/css hrefmain.css>/head>body>	img srcimg/bg-sm.jpg styledisplay:none; altMedac background mobile />	img srcimg/bg.jpg styledisplay:none; altMedac background desktop />	div idvw-test>/div>	section classmain-container>/section>	div classcontent>		div classcontent-inner>			div classlist-content>			h1>Rheumatoid arthritis (RA) is a multisystem autoimmune disordersup>1,2/sup>/h1>			ul>				li>RA is characterized by chronic, destructive inflammation of the synovium/li>				li>RA can lead to bone erosion and weakened muscles and tendons/li>				li>RA affects approximately 1.3 million adults in the United States/li>			/ul>			h1>Goals of treating RAsup>3,4/sup>/h1>			ul>				li>Reach a point of low disease activity/li>				li>If possible, achieve clinical remission of disease/li>			/ul>			h1>DMARDs and Methotrexatesup>5/sup>/h1>			ul>				li>Disease-modifying anti-rheumatic drugs, (DMARDs), are used to inhibit radiographic progression and help reach the goals of treating RA /li>				li>The DMARD methotrexate (MTX) can be administered orally or parenterally (most often using the subcutaneous SC route)/li>			/ul>			h1>Optimizing Methotrexate Treatment in RA/h1>			ul>				li>28% of patients with early, poor-prognosis RA achieve the goal of low disease activity with MTX monotherapy6 /li>				li>The use of SC MTX may help patients stay on MTX treatment longer, and provide

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > ra-option.com

Is this malicious?

DNS Resolutions

Port 80